Published in Surgery on February 06, 2007
Characterization of squamous esophageal cells resistant to bile acids at acidic pH: implication for Barrett's esophagus pathogenesis. Am J Physiol Gastrointest Liver Physiol (2010) 0.92
Chemoprotective effects of curcumin in esophageal epithelial cells exposed to bile acids. World J Gastroenterol (2010) 0.81
Infrared light-absorbing gold/gold sulfide nanoparticles induce cell death in esophageal adenocarcinoma. Int J Nanomedicine (2013) 0.81
Diet composition affects surgery-associated weight loss in rats with a compromised alimentary tract. J Surg Res (2009) 0.79
Anti-Oxidative and Anti-Inflammatory Effects of QGC in Cultured Feline Esophageal Epithelial Cells. Korean J Physiol Pharmacol (2013) 0.79
The resistance of esophageal adenocarcinoma to bile salt insult is associated with manganese superoxide dismutase expression. J Surg Res (2010) 0.79
Dietary freeze-dried black raspberry's effect on cellular antioxidant status during reflux-induced esophagitis in rats. Nutrition (2010) 0.78
From reflux esophagitis to Barrett's esophagus and esophageal adenocarcinoma. World J Gastroenterol (2015) 0.77
Left-sided pancreatectomy: a multicenter comparison of laparoscopic and open approaches. Ann Surg (2008) 2.80
Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial. Gastroenterology (2003) 2.52
Correlation between prognostic factors and increasing age in melanoma. Ann Surg Oncol (2004) 2.18
Perioperative blood transfusion is associated with decreased survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma: a multi-institutional study. J Gastrointest Surg (2014) 2.15
Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures. J Surg Oncol (2012) 1.99
Management of hepatic metastasis of gastrointestinal carcinoid tumors. J Surg Oncol (2008) 1.88
Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma. J Clin Oncol (2006) 1.85
A multicenter analysis of distal pancreatectomy for adenocarcinoma: is laparoscopic resection appropriate? J Am Coll Surg (2010) 1.83
A novel classification scheme for gastroparesis based on predominant-symptom presentation. J Clin Gastroenterol (2008) 1.64
Major hepatectomy with simultaneous pancreatectomy for advanced hepatobiliary cancer. J Am Coll Surg (2004) 1.58
Nutritional management during neoadjuvant therapy for esophageal cancer. J Surg Oncol (2009) 1.54
The Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the U.S. open label trial. Gastrointest Endosc (2002) 1.54
Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy? Cancer (2010) 1.53
Transcatheter treatment of hepatocellular carcinoma with Doxorubicin-loaded DC Bead (DEBDOX): technical recommendations. Cardiovasc Intervent Radiol (2011) 1.48
Assessment of mitotic rate reporting in melanoma. Am J Surg (2012) 1.47
The lower incidence of melanoma in women may be related to increased preventative behaviors. Am J Surg (2010) 1.45
Microwave ablation for hepatic malignancies: a multiinstitutional analysis. Ann Surg (2014) 1.44
Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy. Ann Surg Oncol (2009) 1.44
An evaluation of 2537 gastrointestinal stromal tumors for a proposed clinical staging system. Arch Surg (2009) 1.42
Acceptance of sentinel lymph node biopsy of the breast by all general surgeons in kentucky. Breast J (2005) 1.41
Factors associated with surgical options for breast carcinoma. Cancer (2006) 1.34
Hepatic tumor ablation with clustered microwave antennae: the US Phase II trial. HPB (Oxford) (2007) 1.33
Irreversible electroporation ablation (IRE) of unresectable soft tissue tumors: learning curve evaluation in the first 150 patients treated. PLoS One (2013) 1.32
Gender-related differences in outcome for melanoma patients. Ann Surg (2006) 1.32
Lumpectomy margins are affected by tumor size and histologic subtype but not by biopsy technique. Am J Surg (2004) 1.25
Proton pump inhibitor therapy for suspected GERD-related chronic laryngitis: a meta-analysis of randomized controlled trials. Am J Gastroenterol (2006) 1.21
Preoperative chemotherapy does not increase morbidity or mortality of hepatic resection for colorectal cancer metastases. Ann Surg Oncol (2008) 1.20
Surgical management of pulmonary carcinoid tumors: sublobar resection versus lobectomy. Am J Surg (2012) 1.20
Radiofrequency ablation vs. resection for hepatic colorectal metastasis: therapeutically equivalent? J Gastrointest Surg (2008) 1.18
Diverse antioxidants protect against acetaminophen hepatotoxicity. J Biochem Mol Toxicol (2004) 1.18
Chemoprevention of carcinogenic progression to esophageal adenocarcinoma by the manganese superoxide dismutase supplementation. Clin Cancer Res (2007) 1.14
Laparoscopic left pancreatectomy: complication risk score correlates with morbidity and risk for pancreatic fistula. Ann Surg Oncol (2009) 1.10
A proposed staging system for rectal carcinoid tumors based on an analysis of 4701 patients. Surgery (2008) 1.08
Factors associated with false-negative sentinel lymph node biopsy in melanoma patients. Ann Surg Oncol (2009) 1.08
Safety of hepatic resection in metastatic disease to the liver after yttrium-90 therapy. J Surg Res (2009) 1.06
Flt3-ligand treatment prevents diabetes in NOD mice. Diabetes (2004) 1.06
A statin-regulated microRNA represses human c-Myc expression and function. EMBO Mol Med (2012) 1.03
Stroke volume variation in hepatic resection: a replacement for standard central venous pressure monitoring. Ann Surg Oncol (2013) 1.02
Reflux injury of esophageal mucosa: experimental studies in animal models of esophagitis, Barrett's esophagus and esophageal adenocarcinoma. Dis Esophagus (2007) 1.01
Popliteal lymph node dissection. Ann Surg Oncol (2005) 1.00
Laparoscopic versus open resection of hepatic colorectal metastases. Surgery (2012) 1.00
Is selective internal radioembolization safe and effective for patients with inoperable hepatocellular carcinoma and venous thrombosis? J Am Coll Surg (2009) 0.99
Importance of low preoperative platelet count in selecting patients for resection of hepatocellular carcinoma: a multi-institutional analysis. J Am Coll Surg (2011) 0.99
Financial comparison of laparoscopic versus open hepatic resection using deviation-based cost modeling. Ann Surg Oncol (2013) 0.98
Multi-institutional analysis of pancreatic adenocarcinoma demonstrating the effect of diabetes status on survival after resection. HPB (Oxford) (2012) 0.98
Predicting patients at low probability of requiring postmastectomy radiation therapy. Ann Surg Oncol (2006) 0.98
Factors associated with recurrence and survival following hepatectomy for large hepatocellular carcinoma: a multicenter analysis. J Surg Oncol (2010) 0.98
A proposed staging system for small bowel carcinoid tumors based on an analysis of 6,380 patients. Am J Surg (2008) 0.98
The evolving importance of readmission data to the practicing surgeon. J Am Coll Surg (2010) 0.97
Surgical downstaging and neo-adjuvant therapy in metastatic colorectal carcinoma with irinotecan drug-eluting beads: a multi-institutional study. HPB (Oxford) (2010) 0.97
Ulceration as a predictive marker for response to adjuvant interferon therapy in melanoma. Ann Surg (2010) 0.96
Chemoprotective effects of Curcuma aromatica on esophageal carcinogenesis. Ann Surg Oncol (2008) 0.96
Adjuvant chemoradiation therapy for pancreatic adenocarcinoma: who really benefits? J Am Coll Surg (2009) 0.94
Association of manganese superoxide dismutase expression with progression of carcinogenesis in Barrett esophagus. Arch Surg (2005) 0.92
Prognostic significance of tumor infiltrating lymphocytes in melanoma. Am Surg (2011) 0.92
Cyclooxygenase-2 and epithelial growth factor receptor up-regulation during progression of Barrett's esophagus to adenocarcinoma. World J Gastroenterol (2006) 0.92
Second primary melanomas: incidence and outcome. Am Surg (2010) 0.92
Herbal medicine and hepatocellular carcinoma: applications and challenges. Evid Based Complement Alternat Med (2011) 0.92
Sentinel lymph node biopsy in patients with ductal carcinoma in situ: a proposal. Cancer (2002) 0.91
Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker. Am J Surg (2011) 0.90
Factors determining adequacy of axillary node dissection in breast cancer patients. Breast J (2007) 0.90
Rosai-Dorfman disease of the gastrointestinal tract: report of a case and review of the literature. Int J Surg Pathol (2006) 0.89
Anemia and transfusions in patients undergoing surgery for cancer. Ann Surg Oncol (2007) 0.89
Proximal sensor data from routine dual-sensor esophageal pH monitoring is often inaccurate. Dig Dis Sci (2004) 0.89
Overall survival peri-hilar cholangiocarcinoma: R1 resection with curative intent compared to primary endoscopic therapy. J Surg Oncol (2011) 0.89
Differences in intragastric pH in diabetic vs. idiopathic gastroparesis: relation to degree of gastric retention. Am J Physiol Gastrointest Liver Physiol (2008) 0.88
The prognostic significance of nonsentinel lymph node metastasis in melanoma. Ann Surg Oncol (2010) 0.88
Optimal abdominal incision for partial hepatectomy: increased late complications with Mercedes-type incisions compared to extended right subcostal incisions. World J Surg (2006) 0.88
Proposed staging system for colon carcinoid tumors based on an analysis of 2,459 patients. J Am Coll Surg (2008) 0.88
recurrence following hepatectomy for metastatic colorectal cancer: development of a model that predicts patterns of recurrence and survival. Ann Surg Oncol (2011) 0.87
Hepatic malignant epithelioid hemangioendothelioma: a case report and review of the literature. Am Surg (2008) 0.87
A proposed staging system for gastric carcinoid tumors based on an analysis of 1,543 patients. Ann Surg Oncol (2008) 0.87
Hepatic resection for colorectal liver metastases. Surg Clin North Am (2010) 0.87
Precision hepatic arterial irinotecan therapy in the treatment of unresectable intrahepatic cholangiocellular carcinoma: optimal tolerance and prolonged overall survival. Ann Surg Oncol (2010) 0.87
Are 3 sentinel nodes sufficient? Arch Surg (2007) 0.86
Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma. Am Surg (2011) 0.86
A novel external esophageal perfusion model for reflux esophageal injury. Dig Dis Sci (2006) 0.86
Assessment of chemotherapy response in colorectal liver metastases in patients undergoing hepatic resection and the correlation to pathologic residual viable tumor. J Am Coll Surg (2013) 0.86
Hepatic imaging characteristics predict overall survival in hepatocellular carcinoma. Ann Surg Oncol (2007) 0.86
Lymphovascular invasion as a prognostic factor in melanoma. Am Surg (2011) 0.86
Analysis of 900 appendiceal carcinoid tumors for a proposed predictive staging system. Arch Surg (2008) 0.85
Does mitotic rate predict sentinel lymph node metastasis or survival in patients with intermediate and thick melanoma? Am J Surg (2010) 0.85
Alterations in manganese superoxide dismutase expression in the progression from reflux esophagitis to esophageal adenocarcinoma. Ann Surg Oncol (2007) 0.85
Hepatic tumor ablation: cryo versus radiofrequency, which is better? Am Surg (2006) 0.84
Body mass index influences palpability but not stage of breast cancer at diagnosis. Am Surg (2007) 0.84
Hepatectomy is superior to thermal ablation for patients with a solitary colorectal liver metastasis. J Gastrointest Surg (2010) 0.84
Low-energy DC current ablation in a mouse tumor model. Methods Mol Biol (2014) 0.84